Literature DB >> 17872820

Treating metabolic syndrome: lifestyle change or medication?

Anna Emili1, Hani Abushomar, Kalpana Nair.   

Abstract

Entities:  

Year:  2007        PMID： 17872820      PMCID： PMC1949307     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  8 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 2.  Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence.

Authors:  Earl S Ford
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

3.  The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

Authors:  Trevor J Orchard; Marinella Temprosa; Ronald Goldberg; Steven Haffner; Robert Ratner; Santica Marcovina; Sarah Fowler
Journal:  Ann Intern Med       Date:  2005-04-19       Impact factor: 25.391

Review 4.  Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis.

Authors:  Ivan Tkác
Journal:  Diabetes Res Clin Pract       Date:  2005-03-17       Impact factor: 5.602

5.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

6.  The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  1999-04       Impact factor: 19.112

7.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

Review 8.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122
  8 in total
  3 in total

Review 1.  Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancer.

Authors:  Darren Micallef; Sarah Micallef; Pierre Schembri-Wismayer; Jean Calleja-Agius
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01

2.  GSH levels affect weight loss in individuals with metabolic syndrome and obesity following dietary therapy.

Authors:  Nikolaos Goutzourelas; Marina Orfanou; Ioannis Charizanis; George Leon; Demetrios A Spandidos; Demetrios Kouretas
Journal:  Exp Ther Med       Date:  2018-05-23       Impact factor: 2.447

Review 3.  Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome.

Authors:  Helen H Wang; Dong Ki Lee; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.